Record #60265
Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer
Publisher
Original paper date
Jun 24, 2023
Original DOI
Citation lifecycle
How this paper is being cited
Pre-retraction
6
Same day
0
Post-retraction
3
% post-retraction
33.3%
~3.9 citations/yr before retraction · ~1.8 citations/yr after
— citing papers
Who is still citing this work
Loading…